SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: j bayer who wrote (2914)12/1/1997 11:09:00 AM
From: sailor  Respond to of 23519
 
FDA is only good in the US. My one son just took a job (CS) for a company to work on their FDA approvals. He says it can easily be tens of thousands of pages. Once the data is done it can be used for other approvals when put into other forms. His new employer (no one we discuss on this thread) said he would have to go to the UK to be sure the systems work over there also.

Sailor



To: j bayer who wrote (2914)12/1/1997 11:10:00 AM
From: Whipsaw  Respond to of 23519
 
Does anyone have any perspective on Muse profit margins for sales through Astra and Janssen?



To: j bayer who wrote (2914)12/1/1997 11:36:00 AM
From: Bradpalm1  Read Replies (1) | Respond to of 23519
 
Pfizer submitted for European approval to be concurrent with FDA approval here. When Viagra is approved next Spring it will be launched simultaneously on both sides of the Atlantic.

Could the upcoming news be this long-awaited acquisition of a private urological company?

Bradpalm1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News